MYC and cancer: Myc represents an established target for cancer treatment, as demonstrated by studies in animal models, by drugs that mostly affect Myc transcription like JQ17 and by Myc dominant negatives such as Omomyc, a ninety amino acid long, mutant bHLH-Zip domain8, 9, 10 that affects Myc function at the level of protein interactions and DNA binding11.